Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Margarita E. Ignateva"'
Autor:
Anastasia A. Karlsen, Karen K. Kyuregyan, Olga V. Isaeva, Vera S. Kichatova, Fedor A. Asadi Mobarkhan, Lyudmila V. Bezuglova, Irina G. Netesova, Victor A. Manuylov, Andrey A. Pochtovyi, Vladimir A. Gushchin, Snezhana S. Sleptsova, Margarita E. Ignateva, Mikhail I. Mikhailov
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background The geographic distribution of the hepatitis B virus (HBV) and the hepatitis D virus (HDV) genotypes is uneven. We reconstructed the temporal evolution of HBV and HDV in Yakutia, one of the regions of Russia most affected by HBV a
Externí odkaz:
https://doaj.org/article/2534001ebd934264b6c1834edaea2c71
Autor:
Karen K. Kyuregyan, Maria A. Lopatukhina, Fedor A. Asadi Mobarkhan, Vera S. Kichatova, Ilya A. Potemkin, Olga V. Isaeva, Anastasia A. Karlsen, Elena Yu. Malinnikova, Alla N. Kaira, Tatyana V. Kozhanova, Victor A. Manuylov, Elena P. Mazunina, Evgeniia N. Bykonia, Denis A. Kleymenov, Margarita E. Ignateva, Olga E. Trotsenko, Anna V. Kuznetsova, Anna A. Saryglar, Natalia D. Oorzhak, Victor V. Romanenko, Mikhail I. Mikhailov
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1423 (2022)
The data on hepatitis A virus (HAV) seroprevalence are critical for the implementation of a universal mass vaccination (UMV) strategy. The latter has not been implemented in Russia; however, regional child vaccination programs have been adopted in so
Externí odkaz:
https://doaj.org/article/434c34c1c76e4474bcc16cc90d72ca86
Autor:
Karen K. Kyuregyan, Vera S. Kichatova, Olga V. Isaeva, Ilya A. Potemkin, Elena Yu. Malinnikova, Maria A. Lopatukhina, Anastasia A. Karlsen, Fedor A. Asadi Mobarhan, Eugeniy V. Mullin, Olga S. Slukinova, Margarita E. Ignateva, Snezhana S. Sleptsova, Elena E. Oglezneva, Elena V. Shibrik, Maria G. Isaguliants, Mikhail I. Mikhailov
Publikováno v:
Vaccines, Vol 9, Iss 2, p 82 (2021)
Universal hepatitis B vaccination of newborns was implemented in Russia starting from 1998. From 1998 to 2019, the incidence of acute hepatitis B reduced from 43.8 to 0.57 cases per 100,000 population. Here, we assessed the timely coverage of newborn
Externí odkaz:
https://doaj.org/article/d808c294bcde458ea2f3b4e8aa4360ca
Autor:
Olga S. Slukinova, M A Lopatukhina, Eugeniy V. Mullin, M. I. Mikhailov, K. K. Kyuregyan, I A Potemkin, Fedor A. Asadi Mobarhan, Elena Yu. Malinnikova, Elena E. Oglezneva, O. V. Isaeva, Margarita E. Ignateva, Snezhana S. Sleptsova, Karlsen Aa, Elena V. Shibrik, Maria G. Isaguliants, Vera S. Kichatova
Publikováno v:
Vaccines
Volume 9
Issue 2
Vaccines, Vol 9, Iss 82, p 82 (2021)
Volume 9
Issue 2
Vaccines, Vol 9, Iss 82, p 82 (2021)
Universal hepatitis B vaccination of newborns was implemented in Russia starting from 1998. From 1998 to 2019, the incidence of acute hepatitis B reduced from 43.8 to 0.57 cases per 100,000 population. Here, we assessed the timely coverage of newborn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7f05512fb267ebc6fe37abf2faf8aa
https://doi.org/10.3390/vaccines9020082
https://doi.org/10.3390/vaccines9020082